AU3971500A - Indazole derivatives, preparation and therapeutic application thereof - Google Patents

Indazole derivatives, preparation and therapeutic application thereof

Info

Publication number
AU3971500A
AU3971500A AU39715/00A AU3971500A AU3971500A AU 3971500 A AU3971500 A AU 3971500A AU 39715/00 A AU39715/00 A AU 39715/00A AU 3971500 A AU3971500 A AU 3971500A AU 3971500 A AU3971500 A AU 3971500A
Authority
AU
Australia
Prior art keywords
preparation
therapeutic application
indazole derivatives
indazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39715/00A
Inventor
Lydia Zard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of AU3971500A publication Critical patent/AU3971500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06Oxygen atoms
    • C07D451/12Oxygen atoms acylated by aromatic or heteroaromatic carboxylic acids, e.g. cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU39715/00A 1999-04-16 2000-04-11 Indazole derivatives, preparation and therapeutic application thereof Abandoned AU3971500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9905013A FR2792318B1 (en) 1999-04-16 1999-04-16 INDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR9905013 1999-04-16
PCT/FR2000/000923 WO2000063215A2 (en) 1999-04-16 2000-04-11 Indazole derivatives, preparation and therapeutic application thereof

Publications (1)

Publication Number Publication Date
AU3971500A true AU3971500A (en) 2000-11-02

Family

ID=9544676

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39715/00A Abandoned AU3971500A (en) 1999-04-16 2000-04-11 Indazole derivatives, preparation and therapeutic application thereof

Country Status (3)

Country Link
AU (1) AU3971500A (en)
FR (1) FR2792318B1 (en)
WO (1) WO2000063215A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200533348A (en) 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US7728006B2 (en) 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
JP5086091B2 (en) 2004-11-05 2012-11-28 セラヴァンス, インコーポレーテッド 5-HT4 receptor agonist compounds
DE602005014566D1 (en) 2004-11-05 2009-07-02 Theravance Inc Quinolinone-carboxamide CONNECTIONS
CN101080406A (en) 2004-12-22 2007-11-28 施万制药 Indazole-carboxamide compounds
EP1871772B1 (en) 2005-03-02 2014-09-10 Theravance, Inc. Quinolinone compounds as 5-ht4 receptor agonists
WO2007120599A2 (en) 2006-04-12 2007-10-25 Wyeth Dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy
EP3663723A1 (en) 2018-12-04 2020-06-10 Renishaw PLC Encoder apparatus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0350130A3 (en) * 1988-07-07 1991-07-10 Duphar International Research B.V New substituted 1,7-annelated 1h-indazoles
GB8916682D0 (en) * 1989-07-21 1989-09-06 Beecham Group Plc Pharmaceutical compounds
CA2160420A1 (en) * 1994-10-20 1996-04-21 Haruhiko Kikuchi 5-ht4 receptor agonists
FR2769915B1 (en) * 1997-10-21 2000-10-13 Synthelabo TRICYCLIC INDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Also Published As

Publication number Publication date
WO2000063215A2 (en) 2000-10-26
FR2792318A1 (en) 2000-10-20
FR2792318B1 (en) 2001-06-15
WO2000063215A3 (en) 2001-02-01

Similar Documents

Publication Publication Date Title
AU3957600A (en) Piperidyl-imidazole derivatives, their preparations and therapeutic uses
AU2002340999A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
AU2001282267A1 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
AU2922600A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
AU3956900A (en) Substituted imidazoles, their preparation and use
AU3932999A (en) Pyrazoline derivatives, their preparation and application as medicaments
AU3033100A (en) Substituted imidazoles, their preparation and use
AU715620C (en) Therapeutic methods and uses
AU1164601A (en) Therapeutic use and formulation
HUP0201874A2 (en) Pesticidal indazole and benzotriazole derivatives, preparation and use thereof
AU3971500A (en) Indazole derivatives, preparation and therapeutic application thereof
AU1243399A (en) Imidazole derivatives, preparation and therapeutic application thereof
AU6846500A (en) Novel 8-carbonyl chroman derivatives, preparation and therapeutic use thereof
AU2001284084A1 (en) Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
AU2002229870A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
HUP0203468A3 (en) Betha-d-5-thioxylose derivatives, preparation method and therapeutic use thereof
AU5524400A (en) Novel 6-amino-uracil derivatives, preparation and use thereof
AU2001237518A1 (en) Polyfluoroalkylimidazole derivatives, their preparation and therapeutic application
AU4211997A (en) Tricyclic indazole derivatives, preparation and therapeutic application thereof
AU2526001A (en) 2-phenyl-quinoline derivatives, preparation method and therapeutic use thereof
AU3971800A (en) 2-alkoxy-cyclobutene-3,4-dione derivatives, preparation and therapeutic use thereof
AU3153199A (en) Azacycloalkane derivatives, preparation and therapeutic application
AU2922700A (en) Cyclobutene-3,4-dione derivatives, preparation method and therapeutic use
AU4504201A (en) Drug preparations
AU1566599A (en) 3-oxazol-5-yl-1-oxo-1,2-dihydroisoquinoline-4-propanamide derivatives, preparation and therapeutic application

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase